Loading clinical trials...
Loading clinical trials...
A Phase III Randomized Trial of CHOP Chemotherapy Plus Rituxan (IDEC-C2B8) Versus CHOP Chemotherapy Alone for Newly Diagnosed, Previously Untreated, Aggressive Non-Hodgkin's Lymphoma
Conditions
Interventions
rituximab
CHOP regimen
+4 more
Locations
2
United States
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Start Date
September 1, 1999
Primary Completion Date
December 1, 2000
Completion Date
March 1, 2003
Last Updated
September 23, 2024
NCT07249528
NCT04570423
NCT00131014
NCT03050268
NCT07545603
NCT07137494
Lead Sponsor
University of Nebraska
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions